<DOC>
	<DOCNO>NCT02197650</DOCNO>
	<brief_summary>Early Access Program provide L-asparaginase encapsulate Erythrocyte ( GRASPA® ) patient unable receive form Asparaginase .</brief_summary>
	<brief_title>Expanded Access Program : Safety Erythrocytes Encapsulating L-asparaginase ( GRASPA® ) Combination With Polychemotherapy Patients Under 55 Years Old With Acute Lymphoblastic Leukemia ( ALL ) Risk Receive Other Formulation Asparaginase</brief_title>
	<detailed_description>Some patient eligible clinical trial / program sponsor Erytech Pharma could benefit treated GRASPA . Following discussion French regulatory authority , suggest propose access GRASPA patient unable receive form L-asparaginase eligible ongoing study program . This exploratory study allow `` Expended Access Program '' framework .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Patients ALL de novo relapse refractory Eligible chemotherapy treatment include Lasparaginase Known contraindication and/or risk toxicity Lasparaginase formulation accord investigator opinion base information available Patient 55 year old Patient inform consent provide ( 2 parent need consent child ) . Patient unable receive GRASPA due general visceral condition Absence document serological test HIV , B C hepatitis History grade 3 transfusional incident contraindication receive blood transfusion Patient concomitant treatment likely cause hemolysis Presence specific antierythrocyte antibody prevent get compatible erythrocyte concentrate patient . Patient undergo yellow fever vaccination . Patient phenytoin treatment . Women childbearing potential without effective contraception well pregnant breast feed woman . Patient already include another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>ALL l-asparaginase encapsulate erythrocyte</keyword>
</DOC>